BC

Bayer CropScience Ltd

Q2 FY26Fertilizers & Agrochemicals

Bayer CropScience Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹4,072
Market cap₹19.3K Cr
P/E26.4
Updated23 Aug 2026
Read4 min read

What the Q2 FY26 call signalled

2 of 3 strong

RevenueSlow growth
MarginMargins slightly up
CapexCapex planned

The short version

Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years. Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.

From Bayer CropScience Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Slow growth
  • Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years.
  • Growth driven by a strong, strategic focus on Crop Protection (CP) portfolio backed by innovations and doubling of corn seeds portfolio.
  • Expect steady improvement in profitability alongside revenue growth, aiming for around 100 basis points margin improvement over 2-3 years starting from FY 2024-25.
  • Volume growth is important, but margins have limitations, especially in corn due to higher incremental production costs influenced by weather.
  • Pricing power and competitive positioning through new product launches (e.g., BICOTA, Camalus, Xivana Smart) will support growth.

2 more points from Bayer CropScience Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.
  • Significant new product launches are planned, including major proprietary launch "Plenexos" (insecticide) and other compounds like Xivana Smart targeting fruit and vegetable segments.
  • The company is enhancing backward integration for larger compound manufacturing within India to reduce reliance on imports from high currency countries and improve supply chain resilience.
  • Go-to-market transformation includes shifting focus toward partnerships and digital channels in less profitable areas to improve operational efficiency and margin per head.

2 more points from Bayer CropScience Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided pages from the PDF do not contain any information regarding current, expected order book, or pending orders for Bayer CropScience Limited. The discussions largely revolve around: - Supply chain structure and sourcing strategies. - Margin guidance and cost rationalization.

2 more points from Bayer CropScience Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q2 FY26)

    140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran

  • Sumitomo Chemical India Ltd (Q2 FY26)

    Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…

  • Paradeep Phosphates Ltd (Q2 FY26)

    3,600 crore. Key concall takeaways from Paradeep Phosphates Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

  • Sharda Cropchem Ltd (Q2 FY26)

    Regarding longer-term growth, the management is cautious and does not speculate, but acknowledges that reaching INR10,000 crores in 4 to 5 years could happen…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bayer CropScience Ltd Q2 FY26 results?

Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years. Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹19,338 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bayer CropScience Ltd planning capital expenditure?

Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.